Form 6-K ENI SPA For: Nov 25
Tweet
Share
E-mailNews and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
http://archive.fast-edgar.com/20221130/A8BZO22CZ22FR2Z2222L2MZZN8U8ZZ92DK42
Filed on: November 30, 2022
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Koppers Holdings Inc. Schedules Fourth Quarter and Full-Year 2022 Conference Call
- Janssen Reports Positive Topline Phase 2 Results for Nipocalimab in Pregnant Individuals at High Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
- Centessa Pharmaceuticals to Present Additional Data from Open-Label Extension (OLE) of Phase 2a Study of SerpinPC for Hemophilia at the 16th Annual Congress of the European Association for Haemophilia
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
